Secor Capital Advisors’s Intersect ENT, Inc XENT Stock Holding History

Secor Capital Advisors’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-37,041	Closed	-$1.04M	–	615
2018 Q4	$1.04M	Buy	+37,041	New	+$1.08M	0.14%	216
2018 Q3	–	Sell	-45,335	Closed	-$1.7M	–	611
2018 Q2	$1.7M	Buy	+45,335	New	+$1.78M	0.15%	220
2016 Q3	–	Sell	-17,755	Closed	-$229K	–	701
2016 Q2	$229K	Sell	17,755 -13,595	-43%	-$213K	0.03%	522
2016 Q1	$596K	Buy	+31,350	New	+$568K	0.08%	280
2015 Q4	–	Sell	-18,091	Closed	-$423K	–	672
2015 Q3	$423K	Buy	+18,091	New	+$499K	0.13%	264

Other funds holding XENT

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Secor Capital Advisors's XENT Position: Q1 2019 in Review

Secor Capital Advisors sold out of Intersect ENT, Inc (XENT) in Q1 2019, closing a stake of 37,041 shares — an estimated $1.04M sold.

Secor Capital Advisors first reported a position in XENT in Q3 2015 and held it in 5 quarters. The position peaked at $1.7M in Q2 2018. 136 funds tracked by Wall St. Rank hold XENT as of Q1 2019.

Secor Capital Advisors reported no remaining Intersect ENT, Inc position as of Q1 2019 after selling out during the quarter.
Secor Capital Advisors sold 37,041 Intersect ENT, Inc shares in Q1 2019, an estimated $1.04M.
Secor Capital Advisors first reported a position in Intersect ENT, Inc in Q3 2015 and held it in 5 quarters.
Secor Capital Advisors's Intersect ENT, Inc position peaked at $1.7M in Q2 2018.
136 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2019.

Based on Secor Capital Advisors's 13F filing for Q1 2019, filed 15 May 2019.